Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines;Efecto citoprotector del tacrolimus a dosis bajas sobre islotes de Langeerhans en cultivo sometidos a estímulos por citocinas del rechazo agudo

Cirugia Espanola

Volumn 87, Issue 6, 2010, Pages 372-377

  Balibrea del Castillo, José María ^a   Arias Díaz, Javier ^b   García Martín, María Cruz ^b   Vives Pi, Marta ^c   García Pérez, Juan Carlos ^b,d   Cantero Cid, Ramón ^b,d   Vara Ameigeiras, Elena ^b   Balibrea Cantero, José Luis ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Fundacion Instituto de Investigacion en Servicios de Salud   (Spain)

^d HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

Author keywords

Apoptosis; Immunosuppression; Oxidative stress; Pancreatic islet transplantation; Tacrolimus

Indexed keywords

EID: 77953542506     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/j.ciresp.2010.03.009     Document Type: Article

References (28)

1. Casanova D. Presente y futuro del trasplante de islotes pancreáticos en el tratamiento de la diabetes mellitus. Cir Esp 2009, 85:76-83.
2. Harlan D.M., Kenyon N.S., Korsgren O., Roep B.O. Current advances and travails in islet transplantation. Immunology of Diabetes Society. Diabetes 2009, 58:2175-2184.
3. Hardy M.A., Witkowski P., Sondermeijer H., Harris P. The Long Road to Pancreatic Islet Transplantation. World J Surg 2009, 10.1007/s00268-009-0246-5.
4. Barshes N., Wyllie S., Goss J.A. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005, 77:587-597.
5. Bottino R., Fernandez L.A., Ricordi C., Lehmann R., Tsan M.F., Oliver R., et al. Transplantation of allogenic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998, 47:316-323.
6. Berney T., Molano R.D., Cattan P., Pileggi A., Vizzardelli C., Oliver R., et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001, 71:125-132.
7. Hanley S., Liu S., Lipsett M., Castellarin M., Rosenberg L., Tchervenkov J., et al. Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 2006, 82:813-818.
8. Balibrea del Castillo J.M., Vara-Ameigeiras E., Arias-Diaz J., Garcia Martin M.C., Garcia-Perez J.C., Balibrea Cantero J.L. Estado actual del trasplante de islotes pancreáticos. Cir Esp 2007, 81:177-191.
9. Ryan E.A., Paty B.W., Senior P.A., Bigam D., Alfadhli E., Kneteman N.M., et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069.
10. Gabryel B., Chalimoniuk M., Stolecka A., Waniek K., Langfort J., Malecki A. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. J Pharmacol Sci 2006, 102:77-87.
11. Lagoda G., Jin L., Lehrfeld T.J., Liu T., Burnett A.L. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med 2007, 4(4 Pt 1):908-916.
12. Nir T., Melton D.A., Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 2007, 117:2553-2561.
13. Robertson R.P. Islet transplantation as a treatment for diabetes- A work in progress. N Engl J Med 2004, 350:694-705.
14. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Coth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free Immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
15. Hüser N., Doll D., Altomonte J., Werner M., Kriner M., Preissel A., et al. Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. Arch Pharm Res 2009, 32:215-220.
16. Pereira R., Medeiros Y.S., Fröde T.S. Antiinflammatory effects of Tacrolimus in a mouse model of pleurisy. Transpl Immunol 2006, 16:105-111.
17. Balibrea Del Castillo J.M., García-Martín M.C., Arias-Díaz J., Giné E., Vara E., Balibrea Cantero J.L. Antiapoptotic effect of tacrolimus on cytokine challenged human islets. Cell Transplant 2009, 10.3727/096368909×12483162197240.
18. Stover J.F., Schoning B., Sakowitz O.W., Woiciechowsky C., Unterberg A.W. Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats. J Neurosurg 2001, 94:782-787.
19. St Peter S.D., Moss A.A., Mulligan D.C. Effects of tacrolimus on ischemia-reperfusion injury. Liver Transpl 2003, 9:105-116.
20. Garcia-Criado F.J., Palma-Vargas J.M., Valdunciel-Garcia J.J., Toledo A.H., Misawa K., Gomez-Alonso A., et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997, 64:594-598.
21. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E. Cell death. N Engl J Med 2009, 361:1570-1583.
22. Rabinovitch A., Suarez-Pinzon W., Strynadka K., Ju Q., Edelstein D., Brownlee M., et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 1999, 48:1223-1229.
23. Schaffer M., Fuchs N., Volker J., Schulz T., Kapischke M., Viebahn R. Differential effect of tacrolimus on dermal and intestinal wound healing. J Invest Surg 2005, 18:71-79.
24. Su Y., Shi Y., Shi Y.B. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium. FASEB J 1997, 11:559-565.
25. Hashimoto Y., Matsuoka N., Kawakami A., Tsuboi M., Nakashima T., Eguchi K., et al. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin Exp Immunol 2001, 125:19-24.
26. Hui H., Khoury N., Zhao X., Balkir L., D'Amico E., Bullotta A., et al. Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 2005, 54:424-433.
27. Kang C.B., Tai J., Chia J., Yoon H.S. The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38). FEBS Lett 2005, 579:1469-1476.
28. Shirane M., Nakayama K.I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 2003, 5:28-37.